A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation. The research is described today BioMed Central’s journal BMC Psychiatry.
In addition to the hallucinations that often characterize schizophrenia, patients also have major problems with apathy and lack of motivation. The dopamine hypothesis argues that unusual behaviour associated with schizophrenia can largely be explained by variations in the dopamine function of the brain. Exploring a possible link between dopamine activity and the lack of motivation could be key to developing new approaches to helping such patients cope with life.
In a study funded by the National Institute of Health Research, Dr Graham Murray of the Department of Psychiatry at the University of Cambridge and colleagues studied 18 patients presenting with first-episode psychotic symptoms. They compared the patients' performance against 19 healthy participants in a computerised test of motivated behaviour.
The participants took part in a reaction time test, assigning a reward to each trial. In the control group, almost all individuals reacted faster if the potential reward for completing the task was higher. This well documented phenomenon was observed in less than a quarter of the first-episode psychosis group, suggesting an abnormality in the processing of incentives for their actions. Eleven of these participants were taking atypical antipsychotic medications, which are sometimes thought to be responsible for ‘demotivating’ patients. However, this study found that these medications had no significant effect on the results.
In the past, some critics have suggested that patients’ motivational problems are simply secondary to long-term treatment effects, or institutionalisation, but because the researchers studied young adults at the very early stages of their illness, they could rule out this possibility. "Patients with psychosis already have motivational deficits the first time they present to health services." said Dr Murray. ”Understanding the brain basis of these problems will ultimately help in developing new treatments.”
The next step in demonstrating a link between lack of motivation and the brain's biochemical reward system will be to investigate whether self-motivation can be safely stimulated in patients with psychoses using medication, including drugs that trigger the release of dopamine but which do not worsen their other symptoms.
Source: BioMed Central
Related stories:
Inactivity puts coronary patients in jeopardy, study finds
More doctors should prescribe exercise therapy along with antidepressants for their heart disease patients coping with the blues, according to a study published Tuesday in the Journal of the American Medical Association.
Crossing the digital divide
What will motivate the elderly, the chronically ill and the medically underserved to use interactive information technology systems to actively help manage their own health problems? What barriers have prevented people in these groups from using such systems more widely than they have?
Guidelines for the reporting of health research are underfunded
Although reporting guidelines can improve the accuracy and reliability of research reports, there is little funding available for developing such guidelines, according to a new survey published in the open access journal
PLoS Medicine this week.
Study takes a step toward better defining fatigue
In an effort to better define and ultimately address fatigue more effectively, a qualitative study from The University of Texas M. D. Anderson Cancer Center has identified three primary themes - loss of strength or energy, major effects of fatigue and associated sensations - among patients being treated with standard radiation therapy.
Pediatricians say advice to obese kids and families falls on deaf ears
Pediatricians who talk to obese patients and their families about losing weight feel their conversation makes little difference in encouraging a lifestyle change, a small Saint Louis University study finds.
Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder
Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in
Blood, the official journal of the American Society of Hematology.
Unlocking the mysteries of memory
Stop and think for a moment. What do you remember about your breakfast this morning? One part of your brain will recall the smell of coffee brewing, while another will remember your partner's smile while walking out the door. How does the brain weave together these fragments, and how does it bring them back to conscious life?
Coerced medication used in psychiatric care despite lack of clinical evidence
Researchers are calling for more studies into the practice of forcing psychiatric patients to take medication, after a research review showed that there have been very few rigorous investigations of the procedure.